Boumpas DT - Search Results

1

Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease.

Antoniou KM, Mamoulaki M, Malagari K, Kritikos HD, Bouros D, Siafakas NM, Boumpas DT. Antoniou KM, et al. Among authors: boumpas dt. Clin Exp Rheumatol. 2007 Jan-Feb;25(1):23-8. Clin Exp Rheumatol. 2007. PMID: 17417986 Clinical Trial.

2

Perspective on future therapy of vasculitis.

Boumpas DT, Kritikos HD, Daskalakis NG. Boumpas DT, et al. Curr Rheumatol Rep. 2000 Oct;2(5):423-9. doi: 10.1007/s11926-000-0043-5. Curr Rheumatol Rep. 2000. PMID: 11123093 Review.

3

Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect.

Papadaki HA, Kritikos HD, Gemetzi C, Koutala H, Marsh JC, Boumpas DT, Eliopoulos GD. Papadaki HA, et al. Among authors: boumpas dt. Blood. 2002 Mar 1;99(5):1610-9. doi: 10.1182/blood.v99.5.1610. Blood. 2002. PMID: 11861275 Free article.

4

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy.

Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD. Papadaki HA, et al. Among authors: boumpas dt. Blood. 2002 Jul 15;100(2):474-82. doi: 10.1182/blood-2002-01-0136. Blood. 2002. PMID: 12091338 Free article. Clinical Trial.

5

Non-Hodgkin's lymphoma in patients with systemic lupus erythematosus.

Papadaki HA, Xylouri I, Katrinakis G, Foudoulakis A, Kritikos HD, Stathopoulos EN, Boumpas DT, Eliopoulos GD. Papadaki HA, et al. Among authors: boumpas dt. Leuk Lymphoma. 2003 Feb;44(2):275-9. doi: 10.1080/1042819021000030045. Leuk Lymphoma. 2003. PMID: 12688345

6

Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit.

Sidiropoulos P, Bertsias G, Kritikos HD, Kouroumali H, Voudouris K, Boumpas DT. Sidiropoulos P, et al. Among authors: boumpas dt. Ann Rheum Dis. 2004 Feb;63(2):144-8. doi: 10.1136/ard.2003.015933. Ann Rheum Dis. 2004. PMID: 14722202 Free PMC article. Clinical Trial.

7

Sequential therapies with intravenous cyclophosphamide and oral mycophenolate mofetil or azathioprine are efficacious and safe in proliferative lupus nephritis.

Boumpas DT. Boumpas DT. Clin Exp Rheumatol. 2004 May-Jun;22(3):276-7. Clin Exp Rheumatol. 2004. PMID: 15144119 No abstract available.

8

Ear-nose-throat manifestations of autoimmune rheumatic diseases.

Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT. Papadimitraki ED, et al. Among authors: boumpas dt. Clin Exp Rheumatol. 2004 Jul-Aug;22(4):485-94. Clin Exp Rheumatol. 2004. PMID: 15301251 Review.

9

Intestinal ischemia as the first manifestation of vasculitis.

Passam FH, Diamantis ID, Perisinaki G, Saridaki Z, Kritikos H, Georgopoulos D, Boumpas DT. Passam FH, et al. Among authors: boumpas dt. Semin Arthritis Rheum. 2004 Aug;34(1):431-41. doi: 10.1016/j.semarthrit.2003.12.004. Semin Arthritis Rheum. 2004. PMID: 15305242 Review.

10

Lupus nephritis flares.

Sidiropoulos PI, Kritikos HD, Boumpas DT. Sidiropoulos PI, et al. Among authors: boumpas dt. Lupus. 2005;14(1):49-52. doi: 10.1191/0961203305lu2059oa. Lupus. 2005. PMID: 15732288 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page